Deficiency of Vitamin B12 in Type 2 Diabetic Patients Receiving Metformin Therapy at HMC Hospital Peshawar
DOI:
https://doi.org/10.47672/ajhmn.1051Keywords:
Frequency, Deficiency, Vitamin B12, Type2 Diabetic, Metformin TherapyAbstract
Background: Diabetes mellitus is on the rise at an alarming rate, and it has now become a global issue. Type 2 Diabetic Mellitus is a disease characterized by disturbances in glucose, protein, and fat metabolism. Diabetes has been increasingly common in recent decades, causing significant socioeconomic burden, particularly in poorer countries.
Objective: To investigate the prevalence of vitamin B12 deficiency in Type 2 diabetes patients taking metformin.
Methodology: This study was conducted on T2 diabetic patients in the Diabetic Department of Diabetes and Endocrinology HMC Hospital, Peshawar, for a year (10 February 2019 to 12 March 2020). The demographic data of the recruited patients was obtained after they gave their informed written consent. Patients inquired about their metformin use history, dosage, and duration of type 2 diabetes mellitus. A 5cc venous blood sample was taken from the arm and kept at 4 degrees Celsius. Vitamin B12 levels were measured using enzyme-linked immunoassay assays after serum was withdrawn. ELISA was used to determine the Vitamin B12 level in serums.
Results: A total of 149 people were enrolled in this trial. The patients' average age was 55 years. In this study, there were 67 (38.8%) males and 82 (55.2%) females. The individuals had a 5.12-year history of diabetes mellitus. The average HbA1c level was 8.280.32. The individuals that were included have taken metformin for at least 4.8 years. There were 25 (22.6%) patients using 1000-1500 mg metformin daily, 76 (46.4%) receiving 1500-2000 mg metformin daily, and 48 (40.7%) taking greater than 2000 mg metformin daily. There were 44 patients with a normal BMI, 80 patients who were overweight, and 25 patients who were obese. The average B12 level in the blood was 223pg/ml. Vitamin B12 deficiency was found in 96 (49.1%) of the patients. There was no vitamin B12 deficiency in 53 (45.4%) of the patients.
Recommendations: It is strongly advised based on the findings of this study that Serum cobalamin levels should be measured in Type II diabetes patients who are taking metformin, and patients should be given R.D.A (Recommended Dietary Allowance) multivitamins to avoid sequaela of cobalamin deficiency.
Downloads
References
Wong CW, Leung CS, Leung CP, Cheng JN. Association of metformin use with vitamin B12 deficiency in the institutionalized elderly. Arch Gerontol Geriatr. 2018;79:57–62. doi: 10.1016/j.archger.2018.07.019. [PubMed] [CrossRef] [Google Scholar]
Chapman LE, Darling AL, Brown JE. Association between metformin and vitamin B12 deficiency in patients with type 2 diabetes: A systematic review and meta-analysis. Diabetes Metab. 2016;42:316–27. doi: 10.1016/j.diabet.2016.03.008. [PubMed] [CrossRef] [Google Scholar]
Yang W, Cai X, Wu H, Ji L. Associations between metformin use and vitamin B12 levels, anemia, and neuropathy in patients with diabetes: A meta-analysis. J Diabetes. 2019;11:729–43. doi: 10.1111/1753-0407.12900. [PubMed] [CrossRef] [Google Scholar]
Aroda VR, Edelstein SL, Goldberg RB, Knowler WC, Marcovina SM, Orchard TJ, et al. Long-term metformin use and vitamin B12 deficiency in the Diabetes Prevention Program Outcomes Study. J Clin Endocrinol Metab. 2016;101:1754–61. doi: 10.1210/jc.2015-3754. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
Reinstatler L, Qi YP, Williamson RS, Garn JV, Oakley GP., Jr Association of biochemical B12 deficiency with metformin therapy and vitamin B12 supplements: The National Health and Nutrition Examination Survey, 1999–2006. Diabetes Care. 2012;35:327–33. doi: 10.2337/dc11-1582. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
Beulens JW, Hart HE, Kuijs R, Kooijman-Buiting AM, Rutten GE. Influence of duration and dose of metformin on cobalamin deficiency in type 2 diabetes patients using metformin. Acta Diabetol. 2015;52:47–. doi: 10.1007/s00592-014-0597-8. [PubMed] [CrossRef] [Google Scholar]
de Jager J, Kooy A, Lehert P, Wulffelé MG, van der Kolk J, Bets D, et al. Long term treatment with metformin in patients with type 2 diabetes and risk of vitamin B-12 deficiency: Randomised placebo controlled trial. BMJ. 2010;340:c2181. doi: 10.1136/bmj.c2181. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
Alharbi TJ, Tourkmani AM, Abdelhay O, Alkhashan HI, Al-Asmari AK, Bin Rsheed AM, et al. The association of metformin use with vitamin B12 deficiency and peripheral neuropathy in Saudi individuals with type 2 diabetes mellitus. PLoS One. 2018;13:e0204420. doi: 10.1371/journal.pone.0204420. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
Hendrawati YD, Andrajati R, Supardi S, Ariyani A. The risk of cobalamin deficiency symptoms related to long-term metformin use in T2DM patients. Acta Endocrinol (Buchar) 2018;14:49–54. doi: 10.4183/aeb.2018.49. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
Valdés-Ramos R, Guadarrama-López AL, Martínez-Carrillo BE, Benítez-Arciniega AD. Vitamins and type 2 diabetes mellitus. Endocr Metab Immune Disord Drug Targets. 2015;15:54–63. doi: 10.2174/1871530314666141111103217. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
Yetley EA, Pfeiffer CM, Phinney KW, Bailey RL, Blackmore S, Bock JL, et al. Biomarkers of vitamin B-12 status in NHANES: A roundtable summary. Am J Clin Nutr. 2011;94:S313–21. doi: 10.3945/ajcn.111.013243. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
World Health Organization. Diagnosis and management of iron-deficiency anaemia. Geneva: World Health Organization; WHO/NMH/NHD/MNM/11.1.P.3. [Google Scholar]
Rodríguez-Gutiérrez R, Montes-Villarreal J, Rodríguez-Velver KV, González-Velázquez C, Salcido-Montenegro A, Elizondo-Plazas A, et al. Metformin use and vitamin B12 deficiency: Untangling the association. Am J Med Sci. 2017;354:165–71. doi: 10.1016/j.amjms.2017.04.010. [PubMed] [CrossRef] [Google Scholar]
Elhadd T, Ponirakis G, Dabbous Z, Siddique M, Chinnaiyan S, Malik RA. Metformin use is not associated with B12 deficiency or neuropathy in patients with type 2 diabetes mellitus in Qatar. Front Endocrinol (Lausanne) 2018;9:248. doi: 10.3389/fendo.2018.00248. [PubMed] [CrossRef] [Google Scholar]
Angelousi A, Larger E. Anaemia, a common but often unrecognized risk in diabetic patients: A review. Diabetes Metab. 2015;41:18–27. doi: 10.1016/j.diabet.2014.06.001. [PubMed] [CrossRef] [Google Scholar]
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Muhammad Hussain Afridi, Muhamamd Naeem Khan, Atta Muhammad Khan, Muhammad Abbass, Muhammad Khalid Khan, Wali Gul, Shah Zaib
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution (CC-BY) 4.0 License that allows others to share the work with an acknowledgment of the work’s authorship and initial publication in this journal.
